Market Overview

Analyst Downgrades Halyard Health To Underweight, Sees Pressures As 'Formidable'

Share:
  • Halyard Health Inc (NYSE: HYH) shares have declined 27 percent since July 13, after hovering above the $40 mark for several months.
  • Morgan Stanley’s David R Lewis downgraded the rating on the company from Equal-weight to Underweight, while reducing the price target from $38 to $27.
  • The company’s below peer growth and underappreciated structural issues remain concern areas, Lewis mentioned.

Analyst David R Lewis said that the upcoming group purchasing organization [GPO] “magnify our structural concerns around two-thirds of Halyard’s business.” He added that investors do not seem to be considering that the market has changed in the company’s Surgical & Infection Prevention [S&IP] businesses, which contributes two-thirds of total company sales.

“Halyard has historically seen 1% pricing pressure in this business but we now see 2-3% pricing pressure as more likely with risks to the downside. 100 bps of incremental pricing pressure for S&IP is worth $10mn to the top-line and ~$0.12 (6%) to the bottom line,” Lewis added.

Terming the consensus estimates for 2016 as “potentially 10% too high,” Lewis stated that the company is unlikely to record margin expansion and EPS growth next year.

The Morgan Stanley report noted that the Street is missing several dynamics - price and share pressures in S&IP are not temporary but structural, material margin improvement will take longer and the acceleration in Medical Device is not adequate to offset the pressures in S&IP.

Although Halyard's underperformance and seemingly low multiple may seem intriguing to value-based investors, it does not reflect structural lower growth, Lewis said, while adding Halyard Health’s stock is not “cheap” despite the 40 percent decline from its $50 high in early-April.

Latest Ratings for HYH

DateFirmActionFromTo
Jun 2018Morgan StanleyMaintainsUnderweightUnderweight
Jun 2018Stifel NicolausMaintainsBuyBuy
May 2018Morgan StanleyMaintainsUnderweightUnderweight

View More Analyst Ratings for HYH
View the Latest Analyst Ratings

 

Related Articles (HYH)

View Comments and Join the Discussion!

Posted-In: David R Lewis Morgan StanleyAnalyst Color Downgrades Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
INTCJP MorganMaintains70.0
STMCanaccord GenuityMaintains47.0
ELDeutsche BankMaintains248.0
UAADeutsche BankMaintains13.0
INTCDeutsche BankMaintains55.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com